GLP-1 Receptor Agonist Market Size The global GLP-1 receptor agonist market size was valued at USD 24.4 billion in 2023 and is expected to grow at 9.7% CAGR from 2024 to 2032, driven by rising incidences of type 2 diabetes and obesity globally
This demand trajectory directly translates into sustained API volume requirements that are growing faster than existing production capacity, creating significant commercial incentives for both in-house API expansion and third-party CDMO investment
And in a media cycle where AI-powered one-person billion-dollar company is the most shareable headline imaginable, theres an enormous incentive to present the most favorable version of reality
Pre-Surgery Precautions Because GLP-1 medications slow down gastric emptying, they can increase the risk of aspiration during general anesthesia
Keep the compound in your carry-on luggage, never checked baggage where temperature extremes are common
That means paying attention to: Sleep Quality : Poor sleep messes with the hormones that control hunger, which can work against your GLP-1 medication
